| Similar Articles |
|---|
 |
Financial Planning
May 1, 2008
Elizabeth O'Brien |
The Little Book That Builds Wealth Dorsey, director of equity research at Morningstar, covers various elements that help identify companies with competitive advantage in his new book The Little Book that Builds Wealth.   |
The Motley Fool
August 18, 2010
Rich Greifner |
Is Activision Blizzard Built to Last? Can this company sustain its competitive advantages? |
The Motley Fool
August 18, 2010
Rich Greifner |
Is Netflix Built to Last? Can this company sustain its competitive advantages? |
The Motley Fool
January 4, 2005
Richard Gibbons |
How to Outperform in 2005 Four tips to help find stocks that will beat the market in the year ahead. |
The Motley Fool
July 29, 2010
Brian Orelli |
Buy, Sell, or Hold: Biotech Generics Generic biotech drugs are coming. Hop on. |
The Motley Fool
December 1, 2010
Gerard Torres |
Software Companies With Staying Power Everything you wanted to know about moats, but were afraid to ask. |
The Motley Fool
March 3, 2009
Brian Orelli |
Stop Worrying About Follow-On Biologics They're inevitable, but they won't hurt biotech as much as you might think. |
The Motley Fool
February 27, 2009
Brian Orelli |
Can $634 Billion Save the U.S. Health Care System? The good news is that Obama's budget includes a $634 billion down payment on getting insurance for the 48 million uninsured. The bad news is that the president has to pay for that by cutting costs in other areas. |
The Motley Fool
July 27, 2010
Tom Lydon |
Biotech ETFs Feeling the Winds of Change What's shaking up biotech as patents expire and M&A activity gathers steam? |
The Motley Fool
January 26, 2005
Richard Gibbons |
How to Outperform in 2005 Here are five tips to help investors identify stocks that are set to trounce the market. |
The Motley Fool
August 21, 2007
Sham Gad |
Security Analysis 301: Look for a Wide Moat It's not a coincidence that the world's greatest investor invests big in businesses that have wide moats. |
The Motley Fool
April 29, 2005
Charly Travers |
Value in Drug Stocks? Looking at some big pharma companies and liking what you see? Take a peek at biotech, too. GlaxoSmithKline... Pfizer... Amgen... Genzyme... etc. |
The Motley Fool
June 6, 2005
Alyce Lomax |
Yahoo!'s Bid for Auctions The Internet giant removes listing fees for its U.S. auction site. With eBay's revenue growth slowing and signs that maybe eBay's losing some of its charm, the time to launch an offensive seems a bit overdue. |
The Motley Fool
November 19, 2009
Brian Orelli |
Pfizer's Generic Growth, With a Side of Sashimi A move into Japan isn't a bad idea, but it isn't going to save the company either. |
Managed Care
May 2004 |
Biologics Among Fastest Growers Managed care plans and pharmacy benefit managers can benefit from the strong generic presence in the market, but also face challenges relating to biotech drugs. |
The Motley Fool
January 15, 2008
Rich Greifner |
I Like Big Moats and I Cannot Lie Do you know the most important thing Warren Buffett looks for when evaluating a company? The first thing Buffett looks for is an economic moat -- the bigger, the better. |
The Motley Fool
November 2, 2009
Stephen Mauzy |
Set 'Em and (Possibly) Forget 'Em Enduring companies are found in the most pedestrian of industries. |
The Motley Fool
June 22, 2007
Rick Aristotle Munarriz |
eBay Sees Red and Silver The world's largest online marketplace is ready to give it another go in the world's most populous nation. Investors, take note. |
The Motley Fool
December 26, 2008
Rick Aristotle Munarriz |
The Fall and Fall of eBay Remember when eBay was cool? That's so 2004. |
The Motley Fool
April 13, 2009
Rick Aristotle Munarriz |
eBay Lands in South Korea eBay is buying a 34.2% stake in its South Korean rival Gmarket. |
The Motley Fool
October 18, 2010
Brian Orelli |
Pfizer Flexes Its Generic Muscles The pharma giant moves farther into generic drugs. |
The Motley Fool
November 19, 2004
Whitney Tilson |
The Perfect Business Understanding the quality of a business is critical to being a successful investor, as it is a major determinant of what one should be willing to pay for a stock. |
The Motley Fool
January 30, 2007
Brian Lawler |
Pfizer Fights a Generic Threat Pfizer attempts to fend off a generic threat in Canada for its top drug. It's a trial worth paying attention to for its shareholders, as Canada does represent one of the larger pharmaceutical markets in the world. |
The Motley Fool
November 22, 2010
Dan Dzombak |
This Company Is Unbeatable These companies have unfair advantages. |
The Motley Fool
December 28, 2004
Charly Travers |
It's All in the Delivery If too much risk makes you queasy, these drug companies are for you. SkyePharma... DepoMed... |
The Motley Fool
January 30, 2009
Rick Aristotle Munarriz |
This Is How It's Done, eBay If you want growth in the online auction space, look overseas to foreign auction sites like MercadoLibre and Gmarket. |
The Motley Fool
September 27, 2006
Rick Aristotle Munarriz |
Meg Drops Soup eBay isn't the only company struggling in China. There is an investing lesson here for stateside investors who make the flawed assumption that if something works here, it can be easily ported elsewhere. |
The Motley Fool
January 28, 2008
Mac Greer |
Fool Video: Amazon vs. eBay Can eBay take a bite out of Amazon.com and compete on price in a world of Costcos and Wal-Marts? Does Facebook's social network pose a serious business threat to eBay? These questions are discussed in this video. |
InternetNews
April 16, 2009
Michelle Megna |
eBay Buys South Korean Auction Firm for $1.2B Citing synergy, eBay looks to Asia for revenue growth. |
The Motley Fool
February 22, 2011
Brian Orelli |
A Billion-Dollar Market to Open "Very Soon" Biosimilar drugs are finally coming to the U.S. |
The Motley Fool
December 29, 2005
Rick Aristotle Munarriz |
eBay, Can You Spare a Dime? eBay marks down its listing fees for a day, but it's nothing to be alarmed about. Investors, take note. |
The Motley Fool
December 28, 2006
Chuck Saletta |
Dueling Fools: eBay Bear All told, in eBay, there is a company that doesn't seem all that concerned about defending its turf or rewarding its shareholders. |
The Motley Fool
January 26, 2005
Rick Aristotle Munarriz |
Get Off My Forehead! eBay's latest auction trend may give the company a major headache: a man from Omaha received a $37,325 winning bid in exchange for wearing an ad from a snore remedy provider that will be temporarily tattooed to his forehead. |
The Motley Fool
July 23, 2009
Rich Duprey |
eBay Bids for Respect Earnings could have been worse at eBay. |
Managed Care
February 2008
Martin Sipkoff |
FDA Approach to Generics May Be a Mixed Blessing A recently announced initiative is supposed to speed approval of generic drugs, but does it address some fundamental flaws in the approval process? |
The Motley Fool
December 1, 2011
John Grgurich |
Pfizer Losing Lipitor Patent: What Investors Need to Know The patent ends today. |
The Motley Fool
June 7, 2006
Alyce Lomax |
Golly Gmarket, Yahoo! The Internet giant takes a stake in a South Korean e-commerce company. Better late than never. |
The Motley Fool
January 7, 2010
Brian Orelli |
Pfizer Strides Farther Into Generics Pfizer's new look might be just what the doctor ordered. |
The Motley Fool
June 1, 2007
Brian Lawler |
The Generic Cracks Open for Pfizer Pfizer loses a patent case over its top compound. The larger takeaway from the Lipitor legal saga is that investors always need to be aware of the strength of a drug company's patents throughout the world. |
The Motley Fool
December 20, 2007
Brian Orelli |
2007: The Year Pharma Fell in Love With Biologics The reason for pharma's newfound infatuation for biotech is quite clear. Many pharmaceutical companies are facing a patent cliff in the coming years, and they need to replace their blockbusters with something. |
The Motley Fool
January 8, 2008
Brian Orelli |
Brits May Bludgeon Drug Companies The U.K.'s National Health Service delivers a shock to drugmakers; it is considering a 10% drop in the rate that it pays for drugs, to help it reach its goal of a 3% reduction in the nation's overall health-care bill. |
InternetNews
December 19, 2006
Nicholas Carlson |
EBay To Scuttle Chinese Site EBay plans to turn off its main auctions Web site in China after years of heavy investments. |
The Motley Fool
May 29, 2007
Rick Aristotle Munarriz |
eBay's Siamese Win eBay takes another stab at mattering in Asia. The popular auctioneer is looking to enter Thailand later this year with a Thai-language site that will feed into eBay's many other global trading sites. |
Managed Care
April 2007
Martin Sipkof |
Abbreviated Approval Process In the Works for 'Biosimilar' Drugs The Access to Life-Saving Medicine Act may be a first step to giving the FDA the legal authority to approve these drugs. |
The Motley Fool
April 16, 2009
Rick Aristotle Munarriz |
eBay Hits the "Buy It Now" Button Instead of simply buying a piece of South Korea's leading online marketplace, eBay decides to swallow all of Gmarket. |
The Motley Fool
November 7, 2008
Brian Orelli |
Will Obama Make Your Portfolio Healthy? The changes coming in the health-care industry could be a mixed bag of good and bad for your portfolio. |
The Motley Fool
June 25, 2007
Brian Orelli |
Leading the Pack of Follow-On Drug Makers Generic drug maker Dr. Reddy's Laboratories is taking a huge risk to get ahead of the pack, but it's well worth the rewards of being in front of its competitors. Investors, take note. |
The Motley Fool
August 12, 2010
Brian Orelli |
Pfizer: Strengths, Weaknesses, Opportunities, Threats Knowing them all makes it easier to judge an investment. |
InternetNews
December 20, 2006
Nicholas Carlson |
It's Official: EBay Folds Chinese Subsidiary Hours after announcing plans to leave China, EBay made it official. The online auctioneer will scuttle eBay EachNet, its online, person-to-person trading operation based in Shanghai. |
The Motley Fool
January 28, 2010
Brian Orelli |
Only the Strong Survive at Pfizer The culling of the pipeline isn't as bad as it sounds. |
